DigestRedComo funciona
Red
/
Empresas
Ro
No verificado

Rocket Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaCardiologíaFarmacéuticaMedicina - VariosSalud

28 Comunicados de prensa

Ver todos los comunicados de prensa
25/11/2025
Eventos
Web y redes sociales
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Cardiología
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
06/11/2025
Mercado de valores
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
14/10/2025
Oncología
Salud
Higiene alimentaria
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
10/10/2025
Biotecnología
Finanzas
Salud
Asociaciones/Profesionales
Farmacéutica
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
28/08/2025
Ciencia
Biotecnología
Sanidad
Salud
Farmacéutica
Eventos
Web y redes sociales
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
20/08/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
Industria
Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
07/08/2025
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Cardiología
Mercado de valores
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
24/07/2025
Ciencia
Biotecnología
Medicina - Varios
Biología
Cardiología
Salud
Farmacéutica
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
17/07/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
Industria
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
30/06/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
Industria
Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy
Fuente
Rocket Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0